LNP engineering insights and cell therapy regulatory trends.

Seeking process improvement and support? Our experienced team has answers Join our live Q&A with our cell therapy Fast Trak™ team for insights and answers...

Advancing next-generation T cell therapies requires bridging innovative targeting strategies with scalable, robust manufacturing approaches. Explore how t...

We invite you to watch our webinar on advancing cell therapy manufacturing, with a focus on early-stage and clinical development.

As automated CAR T manufacturing moves toward commercialization, platform selection decisions increasingly depend on objective, comparative data rather tha...

Personalized cancer vaccines (PCVs) are reshaping immuno-oncology. However, translating these therapies into the clinic remains challenging. The progress i...

Gain practical insight into how adeno-associated virus (AAV) production can be scaled from development studies to manufacturing-relevant scale while mainta...

The gene therapy landscape is expanding rapidly, but manufacturing costs remain the primary barrier to commercial and clinical accessibility. Therapy devel...

Ready to accelerate your cell therapy development? Lipid nanoparticles (LNPs) are rapidly emerging as a versatile and scalable delivery platform for cell ...

In this webinar, we explore key considerations and best practices for scaling AAV production, including selecting a transient transfection cell line and sc...

Unlock advanced approaches to scalable plasmid DNA (pDNA) production in this on-demand webinar, designed for CDMOs and Translational Centers seeking to enh...

Cell and gene therapies are entering a transformative era driven by the need for scalable, cost-effective, and safe gene editing and delivery technologies....

When it comes to cell therapy manufacturing, you’re not just in production. You’re crafting hope for millions awaiting these breakthrough treatments. And e...

Cell therapy starting material varies significantly, presenting challenges in maintaining a standardized and reproducible manufacturing process. With the r...

Looking to streamline your CAR T cell process? Discover how lipid nanoparticles (LNP) deliver base editing tools to generate fratricide-resistant CD45-edit...

Delivering nucleic acids using lipid nanoparticles (LNP) to target cells has tremendous potential to enable new cell and gene therapies. In this webinar, w...

Register for this webinar to learn how to improve the quality of your results, view the AKTA oligosynt™ synthesizer and find out how it can maximize your o...

Register for this webinar to: learn about the oligo therapeutic market, gain insight on the challenges you may face when bringing your process in house and...

Register for this webinar to: learn about the complete oligo workflow from Cytiva, find out what reagents are available and how these are optimized for use...

CAR T therapies are gaining increased attention due to their demonstrated potential in patient outcomes. For a successful commercialization of these therap...